Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005133 · ClinicalTrials.gov registry record

Cardiovascular Health Study (CHS)

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Active
Registry status
5,888
Enrollment target
6
Study locations

NCT00005133 is a study of Hypertension and Cardiovascular Diseases that is active but no longer recruiting, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,888 participants, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (68% higher). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005133, a study of Hypertension and Cardiovascular Diseases, is active but no longer recruiting, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

ACTIVE NOT RECRUITING
Registry status
5,888 participants
Enrollment target
6
Study locations

Study Summary

To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.

Study Locations (6)

California

  • University of California, Davis - Sacramento

Maryland

  • Johns Hopkins University - Hagerstown

North Carolina

  • Wake Forest University School of Medicine - Winston-Salem

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Vermont

  • University of Vermont - Colchester

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 5,888 participants
Start Date 1988-06
Est. Completion 2027-12-31

What the Registry Record Tells You About NCT00005133

The ClinicalTrials.gov registry entry for NCT00005133 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,888 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (68% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00005133 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00005133 about?

NCT00005133 is a clinical study titled "Cardiovascular Health Study (CHS)". To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.

What is the current status of trial NCT00005133?

This trial is currently active not recruiting. The enrollment target is 5,888 participants. The study started on 1988-06. Estimated completion is 2027-12-31.

What conditions does trial NCT00005133 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Diabetes Mellitus, Heart Diseases, Coronary Disease.

Who is sponsoring clinical trial NCT00005133?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005133 being conducted?

This trial has 6 study locations across California, Maryland, North Carolina, Pennsylvania, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.